| Kelly Cawcutt, MD | |
|
Emile 42nd St, Omaha, NE 68198-0001 | |
| (402) 559-4015 | |
| (402) 559-5581 |
| Full Name | Kelly Cawcutt |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 16 Years |
| Location | Emile 42nd St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982868436 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that two scientific abstracts on the activity of tranilast against key components of gout - high serum uric acid levels and monosodium urate crystal-induced inflammation - have been accepted for The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology, to be held in Rome, Italy, June 16-19, 2010.
In the U.S. Department of State's DipNote blog, David Lane, U.S. ambassador to the U.N. food and agriculture agencies in Rome, writes about hosting a media tour for journalists, to provide them "an opportunity to see how countries like Tanzania and Malawi are investing in agriculture and in programs to fight hunger and improve nutrition, and how development partners like the United Nations and United States are helping them.
› Verified 6 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that two scientific abstracts on the activity of tranilast against key components of gout - high serum uric acid levels and monosodium urate crystal-induced inflammation - have been accepted for The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology, to be held in Rome, Italy, June 16-19, 2010.
In the U.S. Department of State's DipNote blog, David Lane, U.S. ambassador to the U.N. food and agriculture agencies in Rome, writes about hosting a media tour for journalists, to provide them "an opportunity to see how countries like Tanzania and Malawi are investing in agriculture and in programs to fight hunger and improve nutrition, and how development partners like the United Nations and United States are helping them.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Cawcutt, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-6195 | Kelly Cawcutt, MD Emile 42nd St, Omaha, NE 68198-0001 Ph: (402) 559-4015 |
News Archive
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that two scientific abstracts on the activity of tranilast against key components of gout - high serum uric acid levels and monosodium urate crystal-induced inflammation - have been accepted for The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology, to be held in Rome, Italy, June 16-19, 2010.
In the U.S. Department of State's DipNote blog, David Lane, U.S. ambassador to the U.N. food and agriculture agencies in Rome, writes about hosting a media tour for journalists, to provide them "an opportunity to see how countries like Tanzania and Malawi are investing in agriculture and in programs to fight hunger and improve nutrition, and how development partners like the United Nations and United States are helping them.
› Verified 6 days ago
Dr. Marium Ilahi, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Dr. Vidhya Murukesan, M.B.,B.S Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250 | |
Matthew John Kapalis, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |